Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: DESTINY-PANTUMOUR04
Clinical trial update for the DESTINY-PANTUMOUR04 study sponsored by AstraZeneca, evaluating trastuzumab deruxtecan across multiple cancer t…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: New Technique of Pancreaticojejunostomy During Whipple Operation [NA]
Theodor Bilharz Research Institute completed a clinical trial evaluating a new pancreaticojejunostomy technique used during the Whipple proc…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response [NA]
This document notes an ongoing clinical trial, the MONITOR Study, evaluating remote nutrition monitoring to optimize treatment response in p…
-
CLINICAL_TRIALS other · 2026-03-31Clinical Trial Update: Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2a study of RP-001 in participants with colorectal cancer or pancreatic cancer, with the trial …
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer [Phase 2]
Phase II trial updating the combination of vemurafenib and sorafenib in pancreatic cancer has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
This clinical trial update describes the systematic assessment of hereditary pancreatic cancer risk and its implications for personalized th…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer [Phase 1]
Phase 1B study assessing safety and tolerability of combining canakinumab and tislelizumab with nab-paclitaxel and gemcitabine as neoadjuvan…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
This entry documents the completion of a Phase 1/2 clinical trial evaluating IOA-289, an ATX inhibitor from iOnctura, in patients with metas…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue [NA]
A Memorial Sloan Kettering Cancer Center trial evaluating radiation therapy for solid tumors that have metastasized to soft tissue. The stud…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Immunoparalysis After Pancreaticoduodenectomy
An ongoing clinical trial in Lyon is recruiting to study immunoparalysis after pancreaticoduodenectomy in patients with pancreatic ductal ad…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) [Phase 2]
Phase 2 trial evaluating neoadjuvant mFOLFIRINOX with or without preoperative chemoradiotherapy in borderline resectable pancreatic cancer h…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study) [NA]
Results for the PanECT study evaluating electrochemotherapy on the posterior resection surface to reduce recurrence in pancreatic cancer hav…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Splenic Artery Infusion Chemotherapy vs Systemic Chemotherapy in Advanced Pancreatic Body/Tail Cancer
This completed clinical trial compared splenic artery infusion chemotherapy with standard systemic chemotherapy in patients with unresectabl…
-
CLINICAL_TRIALS withdrawal · 2026-03-27Clinical Trial Update: EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients [NA]
The EpiDetect study, a clinical trial validating a pancreatic cancer detection test in patients with new-onset diabetes, has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Niraparib in Patients With Pancreatic Cancer [Phase 2]
Phase 2 trial of niraparib in pancreatic cancer has completed; the snippet does not include study results.
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial is evaluating a KRAS-specific autologous TCR-T cell therapy for KRAS-mutant advanced solid tumors, including colore…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2)
Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2) from Imperial College London indicates the study is currently recruiting for mu…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma [Phase 2]
Phase 2 trial evaluating stereotactic body radiotherapy in combination with a focal adhesion kinase (FAK) inhibitor for advanced pancreatic …
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating oxaliplatin with irinotecan liposome injection II followed by 5-FU/leucovorin or Tegorgor oral therapy for…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
A recruiting clinical trial (VAPOR2) led by Imperial College London studying volatile organic compound assessment in pancreatic cancer/PDAC.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma
Clinical trial update indicating a study evaluating volatile organic compound assessment in pancreatic ductal adenocarcinoma is currently re…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma. [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial of EUS-guided intra-tumour injection of OncoSil for locally advanced pancreatic cancer has been terminated.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Surveillance of Pancreatic Health After Diabetes Diagnosis [NA]
A recruiting clinical trial sponsored by University Hospital Southampton NHS Foundation Trust to surveil pancreatic health after a diagnosis…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Comparing Two Methods to Follow Patients With Pancreatic Cysts [NA]
This clinical trial update reports on a study comparing two methods to follow patients with pancreatic cancer. The trial is currently active…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study [NA]
This clinical trial is evaluating endoscopic ultrasound-guided radiofrequency ablation for pancreatic tumors and is currently recruiting.